CRMT(CRMT)
CRMT
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $1.40B | $1.44B |
| Low | $1.37B | $1.41B |
| High | $1.43B | $1.47B |
| EBITDA Avg | $117M | $120M |
| Low | $114M | $118M |
| High | $119M | $123M |
| EBIT Avg | $110M | $114M |
| Low | $108M | $111M |
| High | $113M | $116M |
| Net Income Avg | $2M | $20M |
| Low | $2M | $19M |
| High | $2M | $20M |
| EPS Avg | $0.23 | $2.56 |
| Low | $0.22 | $2.49 |
| High | $0.24 | $2.63 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $342M | $350M | $359M | $411M | $330M | $342M | $356M | $394M |
| Low | $334M | $343M | $351M | $402M | $322M | $335M | $348M | $386M |
| High | $349M | $358M | $366M | $419M | $337M | $350M | $364M | $402M |
| EBITDA Avg | $29M | $29M | $30M | $34M | $28M | $29M | $30M | $33M |
| Low | $28M | $29M | $29M | $34M | $27M | $28M | $29M | $32M |
| High | $29M | $30M | $31M | $35M | $28M | $29M | $30M | $34M |
| EBIT Avg | $27M | $28M | $28M | $32M | $26M | $27M | $28M | $31M |
| Low | $26M | $27M | $28M | $32M | $26M | $27M | $28M | $31M |
| High | $28M | $28M | $29M | $33M | $27M | $28M | $29M | $32M |
| Net Income Avg | $-3M | $-3M | $331,897 | $7M | $6M | $2M | $8M | $5M |
| Low | $-3M | $-3M | $322,641 | $7M | $6M | $2M | $8M | $5M |
| High | $-3M | $-3M | $341,153 | $7M | $6M | $2M | $8M | $5M |
| EPS Avg | $-0.31 | $-0.32 | $0.04 | $0.81 | $0.73 | $0.21 | $0.99 | $0.64 |
| Low | $-0.32 | $-0.33 | $0.04 | $0.79 | $0.71 | $0.20 | $0.96 | $0.62 |
| High | $-0.30 | $-0.31 | $0.04 | $0.84 | $0.75 | $0.22 | $1.02 | $0.66 |
| Analysts (Rev / EPS) | 2 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |